GelrinC by Regentis Biomaterials for Cartilage Repair
Regentis Biomaterials is conducting a pivotal FDA regulated clinical study (research study) to evaluate the safety and efficacy of an investigational device, GelrinC, implanted following a standard microfracture procedure, compared to a historical control group of patients who have undergone microfracture for the treatment of articular cartilage defects of the knee. This is a non-randomized [...]